ONCOINVENT ASA (ONCIN.OL) Stock Fundamental Analysis

OSL:ONCIN • NO0013711713

46.02 NOK
+0.51 (+1.11%)
Last: Feb 20, 2026, 10:11 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ONCIN. ONCIN was compared to 52 industry peers in the Pharmaceuticals industry. ONCIN has a great financial health rating, but its profitability evaluates not so good. ONCIN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ONCIN had negative earnings in the past year.
  • In the past year ONCIN has reported a negative cash flow from operations.
  • ONCIN had negative earnings in each of the past 5 years.
  • In the past 5 years ONCIN always reported negative operating cash flow.
ONCIN.OL Yearly Net Income VS EBIT VS OCF VS FCFONCIN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100M -200M -300M

1.2 Ratios

  • ONCIN has a Return On Assets of -160.55%. This is amonst the worse of the industry: ONCIN underperforms 92.31% of its industry peers.
  • ONCIN has a worse Return On Equity (-207.87%) than 84.62% of its industry peers.
Industry RankSector Rank
ROA -160.55%
ROE -207.87%
ROIC N/A
ROA(3y)-126.61%
ROA(5y)-96.68%
ROE(3y)-201.42%
ROE(5y)-144.62%
ROIC(3y)N/A
ROIC(5y)N/A
ONCIN.OL Yearly ROA, ROE, ROICONCIN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ONCIN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ONCIN.OL Yearly Profit, Operating, Gross MarginsONCIN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20K -40K -60K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • ONCIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ONCIN has more shares outstanding
  • Compared to 5 years ago, ONCIN has less shares outstanding
  • Compared to 1 year ago, ONCIN has a worse debt to assets ratio.
ONCIN.OL Yearly Shares OutstandingONCIN.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
ONCIN.OL Yearly Total Debt VS Total AssetsONCIN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 0.86, we must say that ONCIN is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.86, ONCIN is doing worse than 76.92% of the companies in the same industry.
  • ONCIN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACCN/A
WACC8.56%
ONCIN.OL Yearly LT Debt VS Equity VS FCFONCIN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 4.39 indicates that ONCIN has no problem at all paying its short term obligations.
  • ONCIN has a better Current ratio (4.39) than 98.08% of its industry peers.
  • A Quick Ratio of 4.39 indicates that ONCIN has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 4.39, ONCIN belongs to the best of the industry, outperforming 98.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.39
Quick Ratio 4.39
ONCIN.OL Yearly Current Assets VS Current LiabilitesONCIN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 70.32% over the past year.
  • ONCIN shows a strong growth in Revenue. In the last year, the Revenue has grown by 139.55%.
  • Measured over the past years, ONCIN shows a very negative growth in Revenue. The Revenue has been decreasing by -37.51% on average per year.
EPS 1Y (TTM)70.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.07%
Revenue 1Y (TTM)139.55%
Revenue growth 3Y3.09%
Revenue growth 5Y-37.51%
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 25.43% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 227.11% on average over the next years. This is a very strong growth
EPS Next Y97.38%
EPS Next 2Y40.53%
EPS Next 3Y25.43%
EPS Next 5YN/A
Revenue Next Year6400%
Revenue Next 2Y447.72%
Revenue Next 3Y227.11%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ONCIN.OL Yearly Revenue VS EstimatesONCIN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
ONCIN.OL Yearly EPS VS EstimatesONCIN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1K -2K -3K

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • ONCIN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ONCIN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ONCIN.OL Price Earnings VS Forward Price EarningsONCIN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ONCIN.OL Per share dataONCIN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ONCIN's earnings are expected to grow with 25.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.53%
EPS Next 3Y25.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ONCIN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ONCOINVENT ASA

OSL:ONCIN (2/20/2026, 10:11:30 AM)

46.02

+0.51 (+1.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-04
Earnings (Next)02-19
Inst Owners38.67%
Inst Owner ChangeN/A
Ins Owners13.1%
Ins Owner ChangeN/A
Market Cap206.17M
Revenue(TTM)848.00K
Net Income(TTM)-139.28M
Analysts86.67
Price Target2.75 (-94.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 243.12
P/FCF N/A
P/OCF N/A
P/B 3.08
P/tB 3.08
EV/EBITDA N/A
EPS(TTM)-48.72
EYN/A
EPS(NY)-1.23
Fwd EYN/A
FCF(TTM)-30.77
FCFYN/A
OCF(TTM)-30.77
OCFYN/A
SpS0.19
BVpS14.96
TBVpS14.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -160.55%
ROE -207.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-126.61%
ROA(5y)-96.68%
ROE(3y)-201.42%
ROE(5y)-144.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.39
Quick Ratio 4.39
Altman-Z 0.86
F-Score4
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)282.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)412.22%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.07%
EPS Next Y97.38%
EPS Next 2Y40.53%
EPS Next 3Y25.43%
EPS Next 5YN/A
Revenue 1Y (TTM)139.55%
Revenue growth 3Y3.09%
Revenue growth 5Y-37.51%
Sales Q2Q%N/A
Revenue Next Year6400%
Revenue Next 2Y447.72%
Revenue Next 3Y227.11%
Revenue Next 5YN/A
EBIT growth 1Y21.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.32%
EBIT Next 3Y10.33%
EBIT Next 5YN/A
FCF growth 1Y51.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.13%
OCF growth 3YN/A
OCF growth 5YN/A

ONCOINVENT ASA / ONCIN.OL FAQ

What is the ChartMill fundamental rating of ONCOINVENT ASA (ONCIN.OL) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ONCIN.OL.


What is the valuation status of ONCOINVENT ASA (ONCIN.OL) stock?

ChartMill assigns a valuation rating of 1 / 10 to ONCOINVENT ASA (ONCIN.OL). This can be considered as Overvalued.


Can you provide the profitability details for ONCOINVENT ASA?

ONCOINVENT ASA (ONCIN.OL) has a profitability rating of 0 / 10.


What is the financial health of ONCOINVENT ASA (ONCIN.OL) stock?

The financial health rating of ONCOINVENT ASA (ONCIN.OL) is 7 / 10.